Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 9,120 | 2,098 | 4,808 | 3,468 | 5,467 |
| Gross Profit | 9,120 | 2,098 | 4,808 | 3,468 | 5,467 |
| Operating Expenses | 23,078 | 15,756 | 20,706 | 16,814 | 20,974 |
| Operating Income | -13,958 | -13,659 | -15,898 | -13,346 | -15,507 |
| Other Income | -10,501 | 693 | 4,694 | 1,002 | 210 |
| Pre-tax Income | -24,459 | -12,966 | -11,204 | -12,344 | -15,297 |
| Net Income Continuous | -24,459 | -12,966 | -11,204 | -12,344 | -15,297 |
| Minority Interests | -47 | N/A | N/A | N/A | N/A |
| Net Income | $-24,412 | $-12,966 | $-11,204 | $-12,344 | $-15,297 |
| EPS Basic Total Ops | -15.85 | -14.41 | -12.97 | -22.09 | -66.75 |
| EPS Basic Continuous Ops | -15.72 | -14.18 | -12.97 | -18.81 | -38.64 |
| EPS Diluted Total Ops | -15.85 | -14.41 | -12.97 | -22.09 | -66.75 |
| EPS Diluted Continuous Ops | -15.72 | -14.18 | -12.97 | -18.81 | -38.64 |
| EBITDA(a) | $-12,281 | $-12,665 | $-14,944 | $-12,435 | $-14,708 |